A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats
- PMID: 15950411
- DOI: 10.1016/j.ijpharm.2005.04.016
A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats
Abstract
The aim of this study was to develop a microemulsion formulation providing an improved efficacy of orally administered insulin. The microemulsions were prepared using Labrafil M 1944 CS, Phospholipon 90 G (lecithin), absolute alcohol and bi-distilled water. The microemulsions of recombinant human (rh)-insulin and aqueous solution (200 IU/kg) were administered intragastrically by a canulla to diabetic and non-diabetic rats. Aprotinin (2500 KIU/g) was added as the enzyme inhibitor to the formulation. Upon the administration of intragastric rh-insulin solution (IS) to non-diabetic rats, the plasma glucose and insulin levels were not changed significantly. Therefore, the hypoglycemic effect caused by subcutaneous rh-insulin solution (SC), microemulsion containing rh-insulin (IME) and microemulsion containing rh-insulin and aprotinin (IMEA) were analyzed in diabetic rats. The area above the plasma glucose levels time curves (AAC), minimum glucose concentration (Cmin) and time to Cmin (tmin) were derived from the plasma glucose profiles. IME and IMEA caused approximately 30% decrease in plasma glucose levels. The decrease in the plasma glucose levels continued after the 90th min. The highest AAC value was obtained when IMEA was administered to rats. The maximum plasma insulin concentration (Cmax), time to reach Cmax (tmax), terminal half-life (t(1/2)), area under the plasma concentration-time curve (AUC), mean residence time (MRT) and elimination rate constant (k(el)) values were also calculated. It was observed that t(1/2) values varied between 0.53 and 1.31h. No significant difference could be found between the pharmacokinetic parameters of the IME and IMEA administered groups. Addition of aprotinin to the microemulsion containing rh-insulin increased bioavailability when compared to those not containing it, although the difference is not significant.
Similar articles
-
Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.Boll Chim Farm. 2003 Oct;142(8):361-6. Boll Chim Farm. 2003. PMID: 15040468 Clinical Trial.
-
Oral delivery system of insulin microspheres: effect on relative hypoglycemia of diabetic albino rats.Boll Chim Farm. 2004 Oct;143(8):315-8. Boll Chim Farm. 2004. PMID: 15884295
-
The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.J Pharm Pharmacol. 2008 Jan;60(1):99-105. doi: 10.1211/jpp.60.1.0013. J Pharm Pharmacol. 2008. PMID: 18088510
-
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.Int J Pharm. 2009 Sep 8;379(1):51-8. doi: 10.1016/j.ijpharm.2009.06.014. Epub 2009 Jun 21. Int J Pharm. 2009. PMID: 19545616
-
Rectal administration of insulin.Methods Find Exp Clin Pharmacol. 1984 Sep;6(9):513-29. Methods Find Exp Clin Pharmacol. 1984. PMID: 6392794 Review.
Cited by
-
Efficacy of mucoadhesive hydrogel microparticles of whey protein and alginate for oral insulin delivery.Pharm Res. 2013 Mar;30(3):721-34. doi: 10.1007/s11095-012-0913-3. Epub 2012 Oct 24. Pharm Res. 2013. PMID: 23093377
-
Oral self-nanoemulsifying formulation of GLP-1 agonist peptide exendin-4: development, characterization and permeability assesment on Caco-2 cell monolayer.Amino Acids. 2021 Jan;53(1):73-88. doi: 10.1007/s00726-020-02926-0. Epub 2021 Jan 4. Amino Acids. 2021. PMID: 33398527
-
Formulation, characterization and evaluation of the effect of polymer concentration on the release behavior of insulin-loaded Eudragit(®)-entrapped mucoadhesive microspheres.Int J Pharm Investig. 2016 Apr-Jun;6(2):69-77. doi: 10.4103/2230-973X.177806. Int J Pharm Investig. 2016. PMID: 27051626 Free PMC article.
-
Phospholipid complex based nanoemulsion system for oral insulin delivery: preparation, in vitro, and in vivo evaluations.Int J Nanomedicine. 2019 May 1;14:3055-3067. doi: 10.2147/IJN.S198108. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31118622 Free PMC article.
-
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes.J Nanobiotechnology. 2015 Oct 24;13:74. doi: 10.1186/s12951-015-0136-y. J Nanobiotechnology. 2015. PMID: 26498972 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical